VEGFA and renal carcinoma: In human renal carcinoma cells, CA and CAPE suppress tumor angiogenesis by inhibiting the activity of STAT3 and the expression of HIF-1α and Vascular Endothelial Growth Factor (VEGF) (Jung et al., 2007).